dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['nivo', 'cml']
stay tuned for our data on nivo-avd in older adults at #17icml . excellent tolerability and unprecedented 2y pfs of 86% and 2y os of 96.4%. 
Clinician-researcher-educator @MSKCancerCenter Tweets about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews @RoswellPark